MARKET

NXLIW

Nexalin Tech
NXLIW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0167
1.087
0.0403
-
Nexalin Advances Non-Invasive Alzheimer's Therapy Toward FDA Clinical Trials
Reuters · 12/03 13:03
NEXALIN TECHNOLOGY INC - REVIEWED ENDPOINTS FOR ALZHEIMER'S OUTCOMES INCLUDING COGNITIVE ASSESSMENTS
Reuters · 12/03 13:01
NEXALIN TECHNOLOGY COMPLETES FDA Q-SUBMISSION MEETING FOR GEN-2 SYNC™ NEUROSTIMULATION CONSOLE IN ALZHEIMER’S DISEASE PROGRAM
Reuters · 12/03 13:00
NEXALIN TECHNOLOGY INC: INTENDS TO INCORPORATE FDA'S FEEDBACK FROM Q-SUB MEETING INTO ITS FINAL PILOT STUDY PROTOCOL
Reuters · 12/03 13:00
Nexalin Technology Hosts Live Investor Webinar Showcasing Mental Health Innovations
Reuters · 12/02 13:00
Nexalin 15 mA Neurostimulation Device Shows Promise in Treating Gambling and Alcohol Use Disorders
Reuters · 11/18 14:00
Nexalin Technology Secures Exclusive Distribution Agreement With Carmi Masha in Israel
Reuters · 11/13 14:15
NEXALIN TECHNOLOGY’S Q-SUBMISSION FOR GEN-2 SYNC ACCEPTED BY U.S. FDA FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND DEMENTIA
Reuters · 11/05 13:30
More

Webull offers Nexalin Tech stock information, including NASDAQ: NXLIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXLIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NXLIW stock methods without spending real money on the virtual paper trading platform.